SCHOTT
SCHOTT’s glass tubing plant near Mumbai, India, has achieved official good manufacturing practice (GMP) compliance, making it the only supplier of pharmaceutical tubing worldwide that has been recognised as working to GMP standards at all its manufacturing sites.
SCHOTT manufactures glass tubing in Europe, South America and Asia, with a total production capacity of more than 140,000 tonnes. Tubes made of FIOLAX specialty glass are the basis of many pharmaceutical packaging solutions, being converted into syringes, vials, ampoules and cartridges. These containers need to safely store medication, sometimes for years, without compromising the effectiveness of the drug, meaning quality of the glass is key.
“SCHOTT considers quality assurance central to the production of pharmaceutical glass,” explained Dr.-Ing. Karsten Hennig, director of quality management at SCHOTT Tubing. “It is therefore established practice for SCHOTT to work to GMP standards at all our facilities.”
The GMP guidelines comprise a series of general principles, like documentation and hygiene, that must be observed during the manufacturing process. More and more countries are specifying GMP as a statutory requirement that pharmaceutical companies and suppliers of quality related components to the industry must meet.
“In order to provide patients with safe pharmaceutical products of the highest standard, quality has to be made the top priority from the very beginning of the value chain,” Hennig added. "By earning GMP certification at all of our production sites of FIOLAX glass tubing around the world, we are helping our customers eliminate all potential risks facing the patient.”
For more details about SCHOTT FIOLAX glass tubing for pharmaceutical packaging, visit: www.schott.com/tubing/english/special_glass/pharma_packaging.html.